GAMES
2
MIN
30.1
PTS
12.5
REB
0.5
AST
0.5
FG%
38.1
Season averages
| Season | Phase | Team | GP | GS | MIN | PTS | REB | AST | 3PM | S+B | FG% | 3P% | FT% | PIR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABA League | ||||||||||||||
| 2026-27 | Regular season | 2 | 2 | 30.1 | 12.5 | 0.5 | 0.5 | 2.5 | 0.5 | 38.1 | 35.7 | 100.0 | 8.5 | |
| 2025-26 | Regular season | 25 | 21 | 23.9 | 10.6 | 2.0 | 1.6 | 1.8 | 0.6 | 39.0 | 32.9 | 92.5 | 8.0 | |
| 2024-25 | Regular season | 29 | 18 | 25.9 | 8.9 | 1.4 | 1.4 | 2.1 | 0.7 | 37.8 | 35.0 | 70.0 | 5.4 | |
| Basketball Champions League | ||||||||||||||
| 2023-24 | Regular season | SZOM | 6 | 0 | 18.5 | 7.2 | 1.0 | 0.0 | 1.5 | 0.0 | 36.4 | 34.6 | 83.3 | — |
| ABA League | ||||||||||||||
| 2022-23 | Regular season | 19 | 17 | 28.5 | 14.4 | 1.8 | 2.4 | 3.0 | 0.5 | 41.0 | 37.0 | 88.0 | 10.8 | |
Last 5 seasons. Show all 7 seasons →
Advanced — true shooting, usage, per-36 rates
| Season | Phase | GP | MIN | TS% | eFG% | USG% | TOV% | 3PAr | FTr | PTS/36 | REB/36 | AST/36 | S+B/36 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-27 ABA League | Regular season | 2 | 60 | 54.9 | 50.0 | 18.7 | 4.2 | 0.67 | 0.19 | 14.9 | 0.6 | 0.6 | 0.6 |
| 2025-26 ABA League | Regular season | 25 | 598 | 54.9 | 49.5 | 20.9 | 8.7 | 0.64 | 0.24 | 16.0 | 3.0 | 2.3 | 0.9 |
| 2024-25 ABA League | Regular season | 29 | 751 | 52.8 | 51.3 | 17.5 | 7.6 | 0.77 | 0.13 | 12.3 | 1.9 | 1.9 | 0.9 |
| 2023-24 Basketball Champions League | Regular season | 6 | 111 | 56.2 | 50.0 | 18.0 | 5.0 | 0.79 | 0.36 | 14.0 | 1.9 | 0.0 | 0.0 |
| 2022-23 ABA League | Regular season | 19 | 542 | 58.8 | 54.5 | 22.0 | 10.1 | 0.73 | 0.24 | 18.1 | 2.3 | 3.0 | 0.6 |
Box-score approximations: usage without play-by-play, shooting from season totals. Rates are per 36 minutes.
Season
2026-272025-262024-252023-242022-232021-222020-21
Recent form
PointsReboundsAssistsThreesPts+Reb+Ast
Points+Reb+Ast over 14.0 in 4/10
Last 15 games — 2025-26
| Date | Opp | Result | MIN | PTS | REB | AST | 3PM | PRA | +/- |
|---|---|---|---|---|---|---|---|---|---|
| 24 Apr | vs SPA | W 93-83 | 22 | 13 | 1 | 1 | 2 | 15 | +15 |
| 20 Apr | @ MEG | L 72-95 | 21 | 8 | 1 | 0 | 2 | 9 | +7 |
| 10 Apr | @ VIE | W 99-86 | 12 | 5 | 1 | 0 | 1 | 6 | 0 |
| 1 Apr | @ ILI | L 84-98 | 20 | 8 | 1 | 2 | 2 | 11 | -7 |
| 27 Mar | vs ZAD | L 59-79 | 13 | 3 | 0 | 0 | 0 | 3 | -12 |
| 22 Mar | vs MEG | W 96-74 | 21 | 14 | 5 | 1 | 4 | 20 | +12 |
| 18 Mar | vs VIE | L 76-85 | 33 | 14 | 3 | 0 | 2 | 17 | -8 |
| 15 Mar | @ SPA | L 71-92 | 29 | 6 | 1 | 2 | 0 | 9 | -19 |
| 6 Mar | @ ZAD | L 77-106 | 11 | 5 | 0 | 1 | 1 | 6 | -6 |
| 3 Mar | vs ILI | L 107-112 | 32 | 18 | 3 | 3 | 4 | 24 | -7 |
| 2 Feb | @ KRK | L 92-105 | 17 | 0 | 2 | 1 | 0 | 3 | -9 |
| 26 Jan | vs SCD | W 102-94 | 33 | 32 | 5 | 2 | 7 | 39 | +5 |
| 19 Jan | @ BOR | L 84-92 | 24 | 13 | 2 | 2 | 3 | 17 | -19 |
| 12 Jan | vs FMP | L 76-85 | 26 | 9 | 2 | 3 | 0 | 14 | -5 |
| 4 Jan | vs DUB | L 78-92 | 20 | 4 | 1 | 1 | 0 | 6 | -22 |
Splits — 2025-26
| Split | GP | MIN | PTS | REB | AST |
|---|---|---|---|---|---|
| Home venue | 12 | 26.8 | 12.9 | 2.6 | 1.9 |
| Away venue | 13 | 21.3 | 8.5 | 1.4 | 1.2 |
| 2-3 days rest | 2 | 22.3 | 9.5 | 1.5 | 0.5 |
| 4+ days rest | 22 | 24.0 | 11.0 | 2.0 | 1.7 |
| Season opener rest | 1 | 24.1 | 3.0 | 2.0 | 1.0 |
Hit rates by line — Points+Reb+Ast, 2025-26
PointsReboundsAssistsThreesPts+Reb+Ast
| Points+Reb+Ast line | Last 5 | Last 10 | Season |
|---|---|---|---|
| Over 6.5 – 7.5 | 3/560% | 7/1070% | 19/2576% |
| Over 8.5 | 3/560% | 7/1070% | 18/2572% |
| Over 9.5 | 2/540% | 5/1050% | 16/2564% |
| Over 10.5 | 2/540% | 5/1050% | 15/2560% |
| Over 11.5 – 12.5 | 1/520% | 4/1040% | 14/2556% |
| Over 13.5 | 1/520% | 4/1040% | 13/2552% |
| Over 14.5 | 1/520% | 4/1040% | 11/2544% |
| Over 15.5 – 16.5 | 0/50% | 3/1030% | 9/2536% |
| Over 17.5 – 19.5 | 0/50% | 2/1020% | 6/2524% |
| Over 20.5 – 21.5 | 0/50% | 1/1010% | 5/2520% |
| Over 22.5 – 23.5 | 0/50% | 1/1010% | 4/2516% |
How often Antonio Jordano finished above each line. These are our own thresholds, not a sportsbook's — no odds are involved.